mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
2e-16 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-06 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.26 |
5e-05 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.24 |
5e-05 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.25 |
9e-05 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |